Significance of Defective Barrier Function of the Repaired Skin in Diabetic Foot Ulcer Recurrence

Speaker: Chandan K Sen, (Endowed University Professor and Co-Director of the McGowan Institute for Regenerative Medicine and Associate Vice Chancellor for Life Science Innovation and Commercialization at the University of Pittsburgh)

Short Bio

Dr. Chandan K Sen (www.chandansen.org; H-index 110) is an Endowed University Professor and Co-Director of the McGowan Institute for Regenerative Medicine and Associate Vice Chancellor for Life Science Innovation and Commercialization at the University of Pittsburgh. He serves as the Chief Scientific Officer, Wound Services, University of Pittsburgh Medical Center. Dr. Sen has been elected fellow of the National Academy of Inventors. Until recently he was Distinguished Professor and the J. Stanley Battersby Chair of Surgery, and Director of the Indiana Center for Regenerative Medicine and Engineering (ICRME). At Indiana University, he served as Associate Vice President of Research. At the IU School of Medicine, he served as Associate Dean of Research. At IU Health he served as the Executive Director of the Comprehensive Wound Center. Dr. Sen is the national vice chair of the NIH Diabetic Foot consortium. He is the PI of the Pennsylvania Clinical Research Unit and the PI of the first DFC study to complete also known as the “TEWL” study. After completing his Masters of Science in Human Physiology from the University of Calcutta, Dr. Sen received his PhD in Physiology from the University of Eastern Finland. Dr. Sen trained as a postdoctoral fellow at the University of California at Berkeley’s Molecular and Cell Biology department. His first faculty appointment was at the Lawrence Berkeley National Laboratory in California. In fall of 2000, Dr. Sen moved to The Ohio State University where he established a program on tissue injury and repair. At Ohio State, Dr. Sen was tenured John H & Mildred C Lumley Professor of Surgery, Executive Director of The Ohio State University Comprehensive Wound Center and Director of the Ohio State University’s Center for Regenerative Medicine & Cell Based Therapies. He was also the Associate Dean for Research at The Ohio State University Wexner Medical Center for well over a decade. Till August 2018, Dr. Sen served as director of the Innovation program for The Ohio State University’s Center for Clinical and Translational Science and was Professor and Vice Chair of Research of Surgery. In July 2023, Dr. Sen and his entire team moved to the University of Pittsburgh. He continues to be a Professor of Surgery by courtesy at Ohio State and Indiana University. Dr. Sen is a Principal Investigator of several projects including multiple clinical trials. His research has been continuously extramurally funded by prestigious agencies such as five different institutes of the National Institutes of Health, US Department of Defense, US Department of Veteran Affairs and industry. Dr. Sen serves on the editorial board of numerous scientific journals. He is the Editor in Chief of Antioxidants & Redox Signaling (www.liebertpub.com/ars) with a current impact factor of 6.6. He is the Editor in Chief of Advances in Wound Care (impact factor 4.9; highest of all journals wholly dedicated to wound care; www.liebertpub.com/whsyb). Dr. Sen and his team have published over 350 scientific publications. He has an H-index of 110 and is currently cited over 3500 times every year for a total citation of 46,226.